David R Epstein
Director · 8 filings · Latest: Oct 8, 2026
AgomAb Therapeutics NV
Tempus AI, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AGMB | David R Epstein | Director | Oct 8, 2026 | Purchase | $8.90 | 5,000 | $44.5K | 15,000 | |
AGMB | David R Epstein | Director | Oct 6, 2026 | Purchase | $8.70 | 5,000 | $43.5K | 10,000 | |
AGMB | David R Epstein | Director | Oct 5, 2026 | Purchase | $8.57 | 5,000 | $42.9K | 5,000 | |
TEM | David R Epstein | Director | Sep 1, 2026 | Sale | $65.55 | 250 | $16.4K | 30,844 | |
TEM | David R Epstein | Director | Aug 3, 2026 | Sale | $43.40 | 370 | $16.1K | 31,094 | |
TEM | DAVID R. EPSTEIN | — | Aug 3, 2026 | Proposed Sale | $43.87 | 990 | $43.4K | — | |
TEM | David R Epstein | Director | Jun 1, 2026 | Sale | $49.40 | 250 | $12.3K | 31,464 | |
TEM | David R Epstein | Director | Mar 2, 2026 | Sale | $50.69 | 250 | $12.7K | 25,801 | |
TEM | DAVID R. EPSTEIN | — | Mar 2, 2026 | Proposed Sale | $53.25 | 870 | $46.3K | — | |
TEM | David R Epstein | Director | Feb 2, 2026 | Sale | $59.41 | 370 | $22.0K | 26,051 | |
TEM | DAVID R. EPSTEIN | — | Nov 3, 2025 | Proposed Sale | $89.85 | 990 | $89.0K | — | |
TEM | DAVID R. EPSTEIN | — | Aug 1, 2025 | Proposed Sale | $56.59 | 620 | $35.1K | — | |
TEM | DAVID R. EPSTEIN | — | Mar 17, 2025 | Proposed Sale | $47.17 | 1,610 | $75.9K | — | |
TEM | DAVID R. EPSTEIN | — | Dec 11, 2024 | Proposed Sale | $45.00 | 1,240 | $55.8K | — |